Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

LeBrun is a Maryland-based freelance writer with a bachelor's degree in communications. She is a member of the Association of Health Care Journalists and the American Society of Journalists and ...

Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

➕ Follow Luke on X 📺 Check out our podcast: Being Exponential When the first American railroads began reporting revenue in ...

Explore iShares XT ETF: disruptive tech themes, sector mix, valuation vs. S&P 500, and risks of subjective index design. Here ...

In this Crunchbase News Q&A, Gigascale Capital founder Mike Schroepfer discusses the coming power crunch, why infrastructure ...

Cerebral ischemic injury occurs when blood flow drops below a critical level, resulting in an energy failure. The progressive transformation of hypoperfused viable tissue, the ischemic penumbra, into ...

Dario Amodei, CEO and founder of Anthropic, just published an online essay that starts out by comparing AI to the Hobbits in the Lord of the Rings. And that may not be the only piece of fiction in it, ...